Linezolid (LZD)
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), Ain Shams University, Beijing Chest Hospital, London School of Hygiene and Tropical Medicine, Wuhan Pulmonary Hospital
Conditions
BoneDouble J StentImpaired Renal FunctionJointMeningitisMycobacterium Abscessus InfectionNon-Tuberculous Mycobacterial (NTM) PneumoniaSyphilis, Congenital
Phase 1
Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis
Enrolling by invitationNCT06811012
Start: 2024-01-31End: 2025-12-31Target: 24Updated: 2025-02-06
Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis
Enrolling by invitationNCT06811025
Start: 2024-02-01End: 2025-12-31Target: 24Updated: 2025-02-06
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
Enrolling by invitationNCT07228702
Start: 2025-11-30End: 2027-10-31Target: 1Updated: 2025-11-17
Phase 2
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
RecruitingNCT05383742
Start: 2023-12-07End: 2029-09-15Target: 330Updated: 2025-12-02
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Not yet recruitingNCT06921213
Start: 2025-10-01End: 2027-06-30Target: 90Updated: 2025-05-04
Phase 4
Unknown Phase
Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function
CompletedNCT06761131
Start: 2024-05-20End: 2025-06-20Updated: 2025-07-25
6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province
Not yet recruitingNCT07198685
Start: 2025-09-30End: 2028-09-30Target: 52Updated: 2025-09-30